(1->4)-beta-D-glucan multiple interactions EXP 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of SPARC mRNA CTD PMID:36331819 (R)-camphor affects expression EXP 6480464 Camphor analog affects the expression of SPARC mRNA CTD PMID:24704097 1,1-dichloroethene increases expression EXP 6480464 vinylidene chloride results in increased expression of SPARC mRNA CTD PMID:26682919 1,2-dimethylhydrazine multiple interactions EXP 6480464 Folic Acid inhibits the reaction [1 and 2-Dimethylhydrazine results in increased expression of SPARC mRNA] CTD PMID:22206623 1,2-dimethylhydrazine increases expression EXP 6480464 1 and 2-Dimethylhydrazine results in increased expression of SPARC mRNA CTD PMID:22206623 1-[(4-chlorophenyl)-phenylmethyl]-4-methylpiperazine increases expression ISO Sparc (Rattus norvegicus) 6480464 chlorcyclizine results in increased expression of SPARC mRNA CTD PMID:21058326 1-naphthyl isothiocyanate increases expression ISO Sparc (Rattus norvegicus) 6480464 1-Naphthylisothiocyanate results in increased expression of SPARC mRNA CTD PMID:25380136 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of SPARC mRNA CTD PMID:17942748 17alpha-ethynylestradiol multiple interactions EXP 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SPARC mRNA CTD PMID:17942748 17alpha-ethynylestradiol decreases expression ISO Sparc (Rattus norvegicus) 6480464 Ethinyl Estradiol results in decreased expression of SPARC mRNA CTD PMID:17557909 17alpha-ethynylestradiol affects expression ISO Sparc (Rattus norvegicus) 6480464 Ethinyl Estradiol affects the expression of SPARC mRNA CTD PMID:16079270 17beta-estradiol multiple interactions EXP 6480464 [Estradiol co-treated with Progesterone] results in decreased expression of SPARC mRNA CTD PMID:19693291 17beta-estradiol multiple interactions ISO SPARC (Homo sapiens) 6480464 [Estradiol co-treated with TGFB1 protein] results in increased expression of SPARC mRNA CTD PMID:30165855 17beta-estradiol decreases expression EXP 6480464 Estradiol results in decreased expression of SPARC mRNA CTD PMID:19693291 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SPARC mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO SPARC (Homo sapiens) 6480464 Tetrachlorodibenzodioxin affects the expression of SPARC mRNA CTD PMID:36370075 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Sparc (Rattus norvegicus) 6480464 Tetrachlorodibenzodioxin affects the expression of SPARC mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of SPARC mRNA CTD PMID:33956508 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of SPARC mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO SPARC (Homo sapiens) 6480464 Tetrachlorodibenzodioxin results in decreased expression of SPARC mRNA CTD PMID:11489354 more ... 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Sparc (Rattus norvegicus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of SPARC mRNA CTD PMID:11752688 2,4,6-trinitrobenzenesulfonic acid multiple interactions EXP 6480464 Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of SPARC mRNA] more ... CTD PMID:17994277 and PMID:18200517 2,4,6-trinitrobenzenesulfonic acid increases expression EXP 6480464 Trinitrobenzenesulfonic Acid results in increased expression of SPARC mRNA CTD PMID:17994277 and PMID:18200517 3,3',4,4',5-pentachlorobiphenyl increases expression ISO Sparc (Rattus norvegicus) 6480464 3 more ... CTD PMID:20959002 3H-1,2-dithiole-3-thione decreases expression ISO Sparc (Rattus norvegicus) 6480464 1 and 2-dithiol-3-thione results in decreased expression of SPARC mRNA CTD PMID:19162173 4,4'-diaminodiphenylmethane increases expression ISO Sparc (Rattus norvegicus) 6480464 4 and 4'-diaminodiphenylmethane results in increased expression of SPARC mRNA CTD PMID:25380136 4,4'-diaminodiphenylmethane decreases expression EXP 6480464 4 and 4'-diaminodiphenylmethane results in decreased expression of SPARC mRNA CTD PMID:18648102 4,4'-sulfonyldiphenol multiple interactions EXP 6480464 [bisphenol S co-treated with Tretinoin] results in decreased expression of SPARC mRNA CTD PMID:30951980 4,4'-sulfonyldiphenol multiple interactions ISO Sparc (Rattus norvegicus) 6480464 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of SPARC mRNA CTD PMID:36041667 4,4'-sulfonyldiphenol increases methylation EXP 6480464 bisphenol S results in increased methylation of SPARC exon CTD PMID:33297965 4,4'-sulfonyldiphenol increases methylation ISO SPARC (Homo sapiens) 6480464 bisphenol S results in increased methylation of SPARC gene CTD PMID:31601247 4,4'-sulfonyldiphenol increases expression EXP 6480464 bisphenol S results in increased expression of SPARC mRNA CTD PMID:30951980 4-hydroxyphenyl retinamide decreases expression EXP 6480464 Fenretinide results in decreased expression of SPARC mRNA CTD PMID:28973697 5-aza-2'-deoxycytidine increases expression ISO SPARC (Homo sapiens) 6480464 Decitabine results in increased expression of SPARC mRNA and Decitabine results in increased expression of SPARC protein CTD PMID:17397030 and PMID:19177197 5-aza-2'-deoxycytidine multiple interactions ISO SPARC (Homo sapiens) 6480464 [Decitabine affects the methylation of SPARC promoter] which affects the expression of SPARC mRNA more ... CTD PMID:18458674 and PMID:19177197 5-fluorouracil multiple interactions ISO SPARC (Homo sapiens) 6480464 [decitabine affects the methylation of SPARC promoter] which affects the susceptibility to Fluorouracil CTD PMID:18458674 5-fluorouracil affects expression EXP 6480464 Fluorouracil affects the expression of SPARC mRNA CTD PMID:24704097 5-fluorouracil increases response to substance ISO SPARC (Homo sapiens) 6480464 SPARC protein results in increased susceptibility to Fluorouracil CTD PMID:15902309 acetylsalicylic acid multiple interactions ISO SPARC (Homo sapiens) 6480464 Aspirin inhibits the reaction [thrombin receptor-activating peptide SFLLRNPNDKY analog results in increased secretion of SPARC protein] CTD PMID:17303692 acrylamide decreases expression ISO Sparc (Rattus norvegicus) 6480464 Acrylamide results in decreased expression of SPARC mRNA CTD PMID:28959563 aldehydo-D-glucose multiple interactions ISO SPARC (Homo sapiens) 6480464 cobaltiprotoporphyrin inhibits the reaction [Glucose results in decreased expression of SPARC mRNA] CTD PMID:19924377 aldehydo-D-glucose decreases expression ISO SPARC (Homo sapiens) 6480464 Glucose results in decreased expression of SPARC mRNA CTD PMID:19924377 alendronic acid affects expression ISO Sparc (Rattus norvegicus) 6480464 Alendronate affects the expression of SPARC mRNA CTD PMID:16079270 all-trans-retinoic acid multiple interactions EXP 6480464 [bisphenol F co-treated with Tretinoin] results in decreased expression of SPARC mRNA more ... CTD PMID:17994277 and PMID:30951980 all-trans-retinoic acid decreases expression ISO SPARC (Homo sapiens) 6480464 Tretinoin results in decreased expression of SPARC mRNA CTD PMID:33167477 all-trans-retinoic acid increases expression ISO Sparc (Rattus norvegicus) 6480464 Tretinoin results in increased expression of SPARC mRNA CTD PMID:24977338 all-trans-retinoic acid affects expression EXP 6480464 Tretinoin affects the expression of SPARC mRNA CTD PMID:24704097 ammonium chloride affects expression ISO Sparc (Rattus norvegicus) 6480464 Ammonium Chloride affects the expression of SPARC mRNA CTD PMID:16483693 amphetamine increases expression ISO Sparc (Rattus norvegicus) 6480464 Amphetamine results in increased expression of SPARC mRNA CTD PMID:30779732 antirheumatic drug increases expression ISO SPARC (Homo sapiens) 6480464 Antirheumatic Agents results in increased expression of SPARC mRNA CTD PMID:24449571 arachidonic acid decreases expression ISO SPARC (Homo sapiens) 6480464 Arachidonic Acid results in decreased expression of SPARC mRNA CTD PMID:16704987 arsane affects methylation ISO SPARC (Homo sapiens) 6480464 Arsenic affects the methylation of SPARC gene CTD PMID:25304211 arsenic atom affects methylation ISO SPARC (Homo sapiens) 6480464 Arsenic affects the methylation of SPARC gene CTD PMID:25304211 arsenite(3-) decreases expression ISO SPARC (Homo sapiens) 6480464 arsenite results in decreased expression of SPARC mRNA and arsenite results in decreased expression of SPARC protein CTD PMID:23974009 and PMID:26783756 arsenite(3-) increases methylation ISO SPARC (Homo sapiens) 6480464 arsenite results in increased methylation of SPARC promoter CTD PMID:23974009 atrazine decreases expression ISO Sparc (Rattus norvegicus) 6480464 Atrazine results in decreased expression of SPARC mRNA CTD PMID:36841081 avobenzone increases expression ISO SPARC (Homo sapiens) 6480464 avobenzone results in increased expression of SPARC mRNA CTD PMID:31016361 benzene multiple interactions ISO Sparc (Rattus norvegicus) 6480464 [Benzene co-treated with methylmercury II co-treated with Trichloroethylene] results in decreased expression of SPARC mRNA CTD PMID:17905399 benzene decreases expression ISO SPARC (Homo sapiens) 6480464 Benzene results in decreased expression of SPARC mRNA CTD PMID:19162166 benzo[a]pyrene increases expression EXP 6480464 Benzo(a)pyrene results in increased expression of SPARC mRNA CTD PMID:22610609 and PMID:32417428 benzo[a]pyrene increases methylation ISO SPARC (Homo sapiens) 6480464 Benzo(a)pyrene results in increased methylation of SPARC promoter CTD PMID:27901495 benzo[b]fluoranthene increases expression EXP 6480464 benzo(b)fluoranthene results in increased expression of SPARC mRNA CTD PMID:26377693 berberine increases expression ISO SPARC (Homo sapiens) 6480464 Berberine results in increased expression of SPARC mRNA CTD PMID:26478571 bexarotene increases expression ISO SPARC (Homo sapiens) 6480464 bexarotene results in increased expression of SPARC mRNA CTD PMID:17178900 bis(2-chloroethyl) sulfide increases expression ISO SPARC (Homo sapiens) 6480464 Mustard Gas results in increased expression of SPARC mRNA CTD PMID:33491125 bisphenol A affects expression ISO Sparc (Rattus norvegicus) 6480464 bisphenol A affects the expression of SPARC mRNA and bisphenol A affects the expression of SPARC protein CTD PMID:20219716 and PMID:25181051 bisphenol A multiple interactions ISO Sparc (Rattus norvegicus) 6480464 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of SPARC mRNA CTD PMID:36041667 bisphenol A decreases methylation ISO SPARC (Homo sapiens) 6480464 bisphenol A results in decreased methylation of SPARC gene CTD PMID:31601247 bisphenol A increases expression ISO SPARC (Homo sapiens) 6480464 bisphenol A results in increased expression of SPARC mRNA and bisphenol A results in increased expression of SPARC protein CTD PMID:31715268 more ... bisphenol A decreases expression ISO SPARC (Homo sapiens) 6480464 bisphenol A results in decreased expression of SPARC mRNA CTD PMID:29275510 bisphenol A affects expression ISO SPARC (Homo sapiens) 6480464 bisphenol A affects the expression of SPARC mRNA CTD PMID:30903817 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of SPARC mRNA CTD PMID:30951980 bisphenol A decreases expression ISO Sparc (Rattus norvegicus) 6480464 bisphenol A results in decreased expression of SPARC mRNA and bisphenol A results in decreased expression of SPARC protein CTD PMID:20219716 more ... bisphenol F multiple interactions EXP 6480464 [bisphenol F co-treated with Tretinoin] results in decreased expression of SPARC mRNA CTD PMID:30951980 bisphenol F multiple interactions ISO Sparc (Rattus norvegicus) 6480464 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of SPARC mRNA CTD PMID:36041667 bisphenol F increases expression EXP 6480464 bisphenol F results in increased expression of SPARC mRNA CTD PMID:30951980 bleomycin A2 increases response to substance EXP 6480464 SPARC protein results in increased susceptibility to Bleomycin CTD PMID:19446018 boric acid affects expression EXP 6480464 boric acid affects the expression of SPARC mRNA CTD PMID:24704097 buspirone decreases expression ISO Sparc (Rattus norvegicus) 6480464 Buspirone results in decreased expression of SPARC mRNA CTD PMID:24136188 cadmium atom decreases expression ISO SPARC (Homo sapiens) 6480464 Cadmium results in decreased expression of SPARC mRNA and Cadmium results in decreased expression of SPARC protein CTD PMID:20570719 more ... cadmium atom multiple interactions ISO SPARC (Homo sapiens) 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SPARC mRNA CTD PMID:29741670 cadmium atom increases expression ISO Sparc (Rattus norvegicus) 6480464 Cadmium results in increased expression of SPARC mRNA CTD PMID:9232954 cadmium dichloride decreases expression ISO SPARC (Homo sapiens) 6480464 Cadmium Chloride results in decreased expression of SPARC mRNA and Cadmium Chloride results in decreased expression of SPARC protein CTD PMID:20837119 cadmium dichloride multiple interactions ISO SPARC (Homo sapiens) 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SPARC mRNA CTD PMID:29741670 calciol multiple interactions ISO SPARC (Homo sapiens) 6480464 [Cholecalciferol co-treated with beta-glycerophosphoric acid co-treated with Ascorbic Acid] results in increased expression of SPARC protein CTD PMID:17692823 calcitriol increases expression ISO Sparc (Rattus norvegicus) 6480464 Calcitriol results in increased expression of SPARC protein CTD PMID:19092814 camphor affects expression EXP 6480464 Camphor analog affects the expression of SPARC mRNA CTD PMID:24704097 carbamazepine affects expression ISO SPARC (Homo sapiens) 6480464 Carbamazepine affects the expression of SPARC mRNA CTD PMID:25979313 carbon nanotube decreases expression EXP 6480464 Nanotubes and Carbon analog results in decreased expression of SPARC mRNA CTD PMID:25620056 carmustine affects response to substance ISO SPARC (Homo sapiens) 6480464 SPARC mRNA affects the susceptibility to Carmustine CTD PMID:16365179 carnosic acid decreases expression EXP 6480464 salvin results in decreased expression of SPARC protein CTD PMID:35926579 casticin increases expression EXP 6480464 casticin results in increased expression of SPARC mRNA CTD PMID:28444820 casticin decreases expression ISO SPARC (Homo sapiens) 6480464 casticin results in decreased expression of SPARC mRNA CTD PMID:27862857 CGP 52608 multiple interactions ISO SPARC (Homo sapiens) 6480464 CGP 52608 promotes the reaction [RORA protein binds to SPARC gene] CTD PMID:28238834 chlorpyrifos decreases expression EXP 6480464 Chlorpyrifos results in decreased expression of SPARC mRNA CTD PMID:20350560 choline multiple interactions EXP 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of SPARC mRNA CTD PMID:20938992 cisplatin multiple interactions ISO SPARC (Homo sapiens) 6480464 [Cisplatin co-treated with jinfukang] results in decreased expression of SPARC mRNA and [Cisplatin co-treated with Paclitaxel] results in decreased expression of SPARC mRNA CTD PMID:20705681 and PMID:27392435 cisplatin decreases expression ISO SPARC (Homo sapiens) 6480464 Cisplatin results in decreased expression of SPARC mRNA CTD PMID:27392435 copper atom multiple interactions EXP 6480464 [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of SPARC mRNA CTD PMID:15467011 copper atom decreases expression ISO Sparc (Rattus norvegicus) 6480464 Copper results in decreased expression of SPARC mRNA CTD PMID:30556269 copper atom increases expression EXP 6480464 Copper results in increased expression of SPARC mRNA CTD PMID:16629173 copper atom decreases secretion EXP 6480464 Copper results in decreased secretion of SPARC protein CTD PMID:19635393 copper(0) multiple interactions EXP 6480464 [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of SPARC mRNA CTD PMID:15467011 copper(0) decreases expression ISO Sparc (Rattus norvegicus) 6480464 Copper results in decreased expression of SPARC mRNA CTD PMID:30556269 copper(0) increases expression EXP 6480464 Copper results in increased expression of SPARC mRNA CTD PMID:16629173 copper(0) decreases secretion EXP 6480464 Copper results in decreased secretion of SPARC protein CTD PMID:19635393 corn oil increases expression ISO Sparc (Rattus norvegicus) 6480464 Corn Oil results in increased expression of SPARC mRNA CTD PMID:22760963 crocidolite asbestos multiple interactions EXP 6480464 Asbestos more ... CTD PMID:19446018 crocidolite asbestos decreases expression EXP 6480464 Asbestos and Crocidolite results in decreased expression of SPARC mRNA CTD PMID:29279043 crocidolite asbestos decreases expression ISO SPARC (Homo sapiens) 6480464 Asbestos and Crocidolite results in decreased expression of SPARC mRNA CTD PMID:28056339 crocidolite asbestos increases response to substance EXP 6480464 SPARC protein results in increased susceptibility to Asbestos and Crocidolite CTD PMID:19446018 Cuprizon increases expression ISO Sparc (Rattus norvegicus) 6480464 Cuprizone results in increased expression of SPARC mRNA CTD PMID:26577399 curcumin multiple interactions EXP 6480464 Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of SPARC mRNA] CTD PMID:18200517 cyclophosphamide decreases expression EXP 6480464 Cyclophosphamide results in decreased expression of SPARC mRNA CTD PMID:15331540 cyclophosphamide increases expression ISO SPARC (Homo sapiens) 6480464 Cyclophosphamide results in increased expression of SPARC mRNA CTD PMID:17403535 cyclosporin A decreases expression ISO SPARC (Homo sapiens) 6480464 Cyclosporine results in decreased expression of SPARC mRNA CTD PMID:20106945 and PMID:25562108 cytarabine decreases expression ISO SPARC (Homo sapiens) 6480464 Cytarabine results in decreased expression of SPARC mRNA CTD PMID:21198554 D-glucose decreases expression ISO SPARC (Homo sapiens) 6480464 Glucose results in decreased expression of SPARC mRNA CTD PMID:19924377 D-glucose multiple interactions ISO SPARC (Homo sapiens) 6480464 cobaltiprotoporphyrin inhibits the reaction [Glucose results in decreased expression of SPARC mRNA] CTD PMID:19924377 DDT increases expression ISO SPARC (Homo sapiens) 6480464 DDT results in increased expression of SPARC mRNA CTD PMID:25014179 dexamethasone decreases expression ISO Sparc (Rattus norvegicus) 6480464 Dexamethasone results in decreased expression of SPARC mRNA CTD PMID:9232954 dextran sulfate multiple interactions EXP 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of SPARC mRNA CTD PMID:29950665 dioxygen multiple interactions EXP 6480464 GPR68 protein affects the reaction [Oxygen deficiency results in increased expression of SPARC mRNA] CTD PMID:28174749 dioxygen increases expression EXP 6480464 Oxygen deficiency results in increased expression of SPARC mRNA CTD PMID:28174749 diuron decreases expression ISO Sparc (Rattus norvegicus) 6480464 Diuron results in decreased expression of SPARC mRNA CTD PMID:25152437 diuron increases expression ISO Sparc (Rattus norvegicus) 6480464 Diuron results in increased expression of SPARC mRNA CTD PMID:21551480 dorsomorphin multiple interactions ISO SPARC (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SPARC mRNA CTD PMID:27188386 doxorubicin increases expression ISO SPARC (Homo sapiens) 6480464 Doxorubicin results in increased expression of SPARC mRNA CTD PMID:15870702 doxorubicin decreases expression ISO SPARC (Homo sapiens) 6480464 Doxorubicin results in decreased expression of SPARC mRNA CTD PMID:29803840 doxorubicin increases expression EXP 6480464 Doxorubicin results in increased expression of SPARC mRNA CTD PMID:15033991 endosulfan decreases expression ISO Sparc (Rattus norvegicus) 6480464 Endosulfan results in decreased expression of SPARC mRNA CTD PMID:29391264 ethanol increases expression ISO SPARC (Homo sapiens) 6480464 Ethanol results in increased expression of SPARC mRNA CTD PMID:15963989 ethanol decreases expression EXP 6480464 Ethanol results in decreased expression of SPARC mRNA CTD PMID:34755883 ethanol increases expression EXP 6480464 Ethanol results in increased expression of SPARC mRNA CTD PMID:30319688 Ethoxyacetic acid affects expression EXP 6480464 ethoxyacetic acid affects the expression of SPARC mRNA CTD PMID:24704097 fenamidone increases expression EXP 6480464 fenamidone results in increased expression of SPARC mRNA CTD PMID:27029645 fenthion increases expression EXP 6480464 Fenthion results in increased expression of SPARC mRNA CTD PMID:34813904 fipronil increases expression ISO Sparc (Rattus norvegicus) 6480464 fipronil results in increased expression of SPARC mRNA CTD PMID:34044035 folic acid multiple interactions EXP 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of SPARC mRNA more ... CTD PMID:20938992 and PMID:22206623 folic acid increases expression ISO SPARC (Homo sapiens) 6480464 Folic Acid results in increased expression of SPARC mRNA CTD PMID:28752528 folic acid decreases expression EXP 6480464 Folic Acid results in decreased expression of SPARC mRNA CTD PMID:25629700 formaldehyde decreases expression ISO SPARC (Homo sapiens) 6480464 Formaldehyde results in decreased expression of SPARC mRNA CTD PMID:23649840 fulvestrant multiple interactions ISO SPARC (Homo sapiens) 6480464 fulvestrant inhibits the reaction [notoginsenoside R1 results in increased expression of SPARC mRNA] CTD PMID:26362186 furan increases expression ISO Sparc (Rattus norvegicus) 6480464 furan results in increased expression of SPARC mRNA CTD PMID:27387713 furosemide increases expression ISO Sparc (Rattus norvegicus) 6480464 Furosemide results in increased expression of SPARC mRNA CTD PMID:16526316 gallocatechin increases expression ISO Sparc (Rattus norvegicus) 6480464 gallocatechol results in increased expression of SPARC mRNA CTD PMID:21877759 gamma-aminobutyric acid affects expression ISO Sparc (Rattus norvegicus) 6480464 gamma-Aminobutyric Acid affects the expression of SPARC mRNA CTD PMID:24098073 gamma-Oryzanol (TN) affects expression ISO Sparc (Rattus norvegicus) 6480464 gamma-oryzanol affects the expression of SPARC mRNA CTD PMID:24098073 genistein increases expression ISO Sparc (Rattus norvegicus) 6480464 Genistein results in increased expression of SPARC mRNA CTD PMID:21877759 glucose decreases expression ISO SPARC (Homo sapiens) 6480464 Glucose results in decreased expression of SPARC mRNA CTD PMID:19924377 glucose multiple interactions ISO SPARC (Homo sapiens) 6480464 cobaltiprotoporphyrin inhibits the reaction [Glucose results in decreased expression of SPARC mRNA] CTD PMID:19924377 glycerol 2-phosphate multiple interactions ISO SPARC (Homo sapiens) 6480464 [Cholecalciferol co-treated with beta-glycerophosphoric acid co-treated with Ascorbic Acid] results in increased expression of SPARC protein CTD PMID:17692823 hydrogen peroxide increases expression ISO SPARC (Homo sapiens) 6480464 Hydrogen Peroxide results in increased expression of SPARC mRNA CTD PMID:34581912 indometacin multiple interactions EXP 6480464 Indomethacin promotes the reaction [Trinitrobenzenesulfonic Acid results in increased expression of SPARC mRNA] CTD PMID:17994277 isoflavones affects expression ISO SPARC (Homo sapiens) 6480464 Isoflavones affects the expression of SPARC mRNA CTD PMID:16365062 L-ascorbic acid multiple interactions ISO SPARC (Homo sapiens) 6480464 [Cholecalciferol co-treated with beta-glycerophosphoric acid co-treated with Ascorbic Acid] results in increased expression of SPARC protein CTD PMID:17692823 L-ascorbic acid 2-phosphate decreases expression ISO SPARC (Homo sapiens) 6480464 ascorbate-2-phosphate results in decreased expression of SPARC mRNA CTD PMID:17306970 L-methionine multiple interactions EXP 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of SPARC mRNA CTD PMID:20938992 lipopolysaccharide increases expression EXP 6480464 Lipopolysaccharides results in increased expression of SPARC mRNA CTD PMID:27339419 losartan decreases expression ISO Sparc (Rattus norvegicus) 6480464 Losartan results in decreased expression of SPARC mRNA CTD PMID:15100363 magnesium atom increases expression ISO SPARC (Homo sapiens) 6480464 Magnesium results in increased expression of SPARC protein CTD PMID:10397942 methamphetamine decreases expression EXP 6480464 Methamphetamine results in decreased expression of SPARC mRNA CTD PMID:36914120 methyl methanesulfonate decreases expression ISO SPARC (Homo sapiens) 6480464 Methyl Methanesulfonate results in decreased expression of SPARC mRNA CTD PMID:23649840 methylmercury chloride decreases expression ISO SPARC (Homo sapiens) 6480464 methylmercuric chloride results in decreased expression of SPARC mRNA CTD PMID:23179753 methylmercury(1+) increases expression ISO Sparc (Rattus norvegicus) 6480464 methylmercury II results in increased expression of SPARC mRNA CTD PMID:17905399 methylmercury(1+) multiple interactions ISO Sparc (Rattus norvegicus) 6480464 [Benzene co-treated with methylmercury II co-treated with Trichloroethylene] results in decreased expression of SPARC mRNA CTD PMID:17905399 N-ethyl-N-nitrosourea increases expression ISO Sparc (Rattus norvegicus) 6480464 Ethylnitrosourea results in increased expression of SPARC mRNA CTD PMID:15954086 N-methyl-4-phenylpyridinium decreases expression ISO Sparc (Rattus norvegicus) 6480464 1-Methyl-4-phenylpyridinium results in decreased expression of SPARC mRNA CTD PMID:28801915 N-methyl-N'-nitro-N-nitrosoguanidine decreases expression ISO SPARC (Homo sapiens) 6480464 Methylnitronitrosoguanidine results in decreased expression of SPARC mRNA CTD PMID:12634122 N-nitrosodiethylamine increases expression ISO Sparc (Rattus norvegicus) 6480464 Diethylnitrosamine results in increased expression of SPARC mRNA CTD PMID:19638242 N-nitrosodiethylamine multiple interactions ISO Sparc (Rattus norvegicus) 6480464 [Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of SPARC mRNA CTD PMID:28943392 N-nitrosodiethylamine increases expression EXP 6480464 Diethylnitrosamine results in increased expression of SPARC mRNA CTD PMID:24535843 N-nitrosodimethylamine increases expression ISO Sparc (Rattus norvegicus) 6480464 Dimethylnitrosamine results in increased expression of SPARC mRNA CTD PMID:25380136 nefazodone decreases expression ISO Sparc (Rattus norvegicus) 6480464 nefazodone results in decreased expression of SPARC mRNA CTD PMID:24136188 nimesulide decreases expression ISO Sparc (Rattus norvegicus) 6480464 nimesulide results in decreased expression of SPARC mRNA CTD PMID:24136188 notoginsenoside R1 multiple interactions ISO SPARC (Homo sapiens) 6480464 fulvestrant inhibits the reaction [notoginsenoside R1 results in increased expression of SPARC mRNA] CTD PMID:26362186 notoginsenoside R1 increases expression ISO SPARC (Homo sapiens) 6480464 notoginsenoside R1 results in increased expression of SPARC mRNA CTD PMID:26362186 oxaliplatin multiple interactions ISO Sparc (Rattus norvegicus) 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of SPARC mRNA CTD PMID:25729387 oxaliplatin increases expression ISO Sparc (Rattus norvegicus) 6480464 oxaliplatin results in increased expression of SPARC mRNA CTD PMID:25729387 p-toluidine decreases expression ISO Sparc (Rattus norvegicus) 6480464 4-toluidine results in decreased expression of SPARC mRNA CTD PMID:27638505 paclitaxel multiple interactions ISO SPARC (Homo sapiens) 6480464 [Cisplatin co-treated with Paclitaxel] results in decreased expression of SPARC mRNA CTD PMID:20705681 paclitaxel increases expression ISO SPARC (Homo sapiens) 6480464 Paclitaxel results in increased expression of SPARC mRNA CTD PMID:19682730 palbociclib increases expression ISO SPARC (Homo sapiens) 6480464 palbociclib results in increased expression of SPARC mRNA CTD PMID:28620137 paracetamol affects expression EXP 6480464 Acetaminophen affects the expression of SPARC mRNA CTD PMID:17562736 paracetamol decreases expression ISO Sparc (Rattus norvegicus) 6480464 Acetaminophen results in decreased expression of SPARC mRNA CTD PMID:33387578 paracetamol decreases expression ISO SPARC (Homo sapiens) 6480464 Acetaminophen results in decreased expression of SPARC mRNA CTD PMID:29067470 perfluorononanoic acid decreases expression ISO SPARC (Homo sapiens) 6480464 perfluoro-n-nonanoic acid results in decreased expression of SPARC mRNA CTD PMID:32588087 perfluorooctane-1-sulfonic acid affects expression ISO SPARC (Homo sapiens) 6480464 perfluorooctane sulfonic acid affects the expression of SPARC mRNA CTD PMID:30738844 perfluorooctane-1-sulfonic acid multiple interactions EXP 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of SPARC mRNA CTD PMID:36331819 phenobarbital affects expression ISO SPARC (Homo sapiens) 6480464 Phenobarbital affects the expression of SPARC mRNA CTD PMID:19159669 phenylmercury acetate increases expression ISO SPARC (Homo sapiens) 6480464 Phenylmercuric Acetate results in increased expression of SPARC mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO SPARC (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SPARC mRNA CTD PMID:27188386 piroxicam decreases expression ISO SPARC (Homo sapiens) 6480464 Piroxicam results in decreased expression of SPARC mRNA CTD PMID:21858171 poly(vinylpyrrolidone) multiple interactions ISO Sparc (Rattus norvegicus) 6480464 [Silver analog co-treated with Povidone] results in decreased expression of SPARC mRNA CTD PMID:25194297 potassium dichromate increases expression EXP 6480464 Potassium Dichromate results in increased expression of SPARC mRNA CTD PMID:23608068 progesterone multiple interactions EXP 6480464 [Estradiol co-treated with Progesterone] results in decreased expression of SPARC mRNA CTD PMID:19693291 raloxifene affects expression ISO Sparc (Rattus norvegicus) 6480464 Raloxifene Hydrochloride affects the expression of SPARC mRNA CTD PMID:16079270 resveratrol decreases expression ISO SPARC (Homo sapiens) 6480464 resveratrol results in decreased expression of SPARC mRNA and resveratrol results in decreased expression of SPARC protein CTD PMID:16084059 resveratrol decreases expression ISO Sparc (Rattus norvegicus) 6480464 resveratrol results in decreased expression of SPARC mRNA CTD PMID:19228061 rimonabant affects expression EXP 6480464 Rimonabant affects the expression of SPARC mRNA CTD PMID:19030233 rimonabant multiple interactions EXP 6480464 Rimonabant inhibits the reaction [Dietary Fats results in increased expression of SPARC mRNA] CTD PMID:19030233 rotenone affects expression ISO Sparc (Rattus norvegicus) 6480464 Rotenone affects the expression of SPARC mRNA CTD PMID:28374803 SB 431542 multiple interactions ISO SPARC (Homo sapiens) 6480464 [LDN 193189 co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 and PMID:37664457 serpentine asbestos decreases expression ISO SPARC (Homo sapiens) 6480464 Asbestos and Serpentine results in decreased expression of SPARC mRNA CTD PMID:21148743 silicon dioxide decreases expression ISO Sparc (Rattus norvegicus) 6480464 Silicon Dioxide results in decreased expression of SPARC mRNA CTD PMID:22431001 silver atom multiple interactions ISO Sparc (Rattus norvegicus) 6480464 [Silver analog co-treated with Povidone] results in decreased expression of SPARC mRNA CTD PMID:25194297 silver(0) multiple interactions ISO Sparc (Rattus norvegicus) 6480464 [Silver analog co-treated with Povidone] results in decreased expression of SPARC mRNA CTD PMID:25194297 sodium arsenite multiple interactions ISO SPARC (Homo sapiens) 6480464 [sodium arsenite affects the acetylation of H3-4 protein] which affects the methylation of SPARC promoter CTD PMID:18448484 sodium arsenite increases expression ISO SPARC (Homo sapiens) 6480464 sodium arsenite results in increased expression of SPARC mRNA CTD PMID:20371982 sodium arsenite decreases expression ISO SPARC (Homo sapiens) 6480464 sodium arsenite results in decreased expression of SPARC mRNA and sodium arsenite results in decreased expression of SPARC protein CTD PMID:20837119 sodium arsenite decreases expression EXP 6480464 sodium arsenite results in decreased expression of SPARC mRNA CTD PMID:18812580 and PMID:36209798 sodium fluoride multiple interactions ISO Sparc (Rattus norvegicus) 6480464 DKK1 protein inhibits the reaction [Sodium Fluoride results in increased expression of SPARC mRNA] CTD PMID:24300170 sodium fluoride increases expression ISO Sparc (Rattus norvegicus) 6480464 Sodium Fluoride results in increased expression of SPARC mRNA CTD PMID:24300170 Soman increases expression ISO Sparc (Rattus norvegicus) 6480464 Soman results in increased expression of SPARC mRNA CTD PMID:19281266 streptozocin increases expression EXP 6480464 Streptozocin results in increased expression of SPARC mRNA and Streptozocin results in increased expression of SPARC protein CTD PMID:12660331 sunitinib decreases expression ISO SPARC (Homo sapiens) 6480464 Sunitinib results in decreased expression of SPARC mRNA CTD PMID:31533062 temozolomide affects response to substance ISO SPARC (Homo sapiens) 6480464 SPARC mRNA affects the susceptibility to temozolomide CTD PMID:16365179 tert-butyl hydroperoxide decreases expression ISO SPARC (Homo sapiens) 6480464 tert-Butylhydroperoxide results in decreased expression of SPARC mRNA CTD PMID:15336504 tert-butyl hydroperoxide increases expression ISO SPARC (Homo sapiens) 6480464 tert-Butylhydroperoxide results in increased expression of SPARC mRNA CTD PMID:15963989 testosterone increases expression EXP 6480464 Testosterone results in increased expression of SPARC mRNA CTD PMID:19693291 tetrachloromethane affects expression EXP 6480464 Carbon Tetrachloride affects the expression of SPARC mRNA CTD PMID:17484886 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of SPARC mRNA CTD PMID:27339419 more ... tetrachloromethane increases expression ISO Sparc (Rattus norvegicus) 6480464 Carbon Tetrachloride results in increased expression of SPARC mRNA CTD PMID:16239168 and PMID:17056239 thioacetamide multiple interactions EXP 6480464 SPARC protein affects the reaction [Thioacetamide results in increased expression of COL1A2 mRNA] more ... CTD PMID:23408952 thioacetamide multiple interactions ISO Sparc (Rattus norvegicus) 6480464 [Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of SPARC mRNA CTD PMID:28943392 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of SPARC mRNA CTD PMID:23408952 thioacetamide affects response to substance EXP 6480464 SPARC protein affects the susceptibility to Thioacetamide CTD PMID:23408952 titanium dioxide decreases expression EXP 6480464 titanium dioxide results in decreased expression of SPARC mRNA CTD PMID:23557971 titanium dioxide multiple interactions EXP 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of SPARC mRNA CTD PMID:29950665 topotecan increases expression ISO Sparc (Rattus norvegicus) 6480464 Topotecan results in increased expression of SPARC mRNA CTD PMID:25729387 topotecan multiple interactions ISO Sparc (Rattus norvegicus) 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of SPARC mRNA CTD PMID:25729387 Trapidil multiple interactions ISO Sparc (Rattus norvegicus) 6480464 Trapidil affects the reaction [PTH protein affects the expression of SPARC mRNA] CTD PMID:18635661 triacsin C decreases expression ISO SPARC (Homo sapiens) 6480464 triacsin C results in decreased expression of SPARC mRNA CTD PMID:16704987 trichloroethene multiple interactions ISO Sparc (Rattus norvegicus) 6480464 [Benzene co-treated with methylmercury II co-treated with Trichloroethylene] results in decreased expression of SPARC mRNA CTD PMID:17905399 trichloroethene increases expression ISO Sparc (Rattus norvegicus) 6480464 Trichloroethylene results in increased expression of SPARC mRNA CTD PMID:19448997 triclosan increases expression ISO SPARC (Homo sapiens) 6480464 Triclosan results in increased expression of SPARC mRNA CTD PMID:30510588 triptonide decreases expression EXP 6480464 triptonide results in decreased expression of SPARC mRNA CTD PMID:33045310 valproic acid affects expression EXP 6480464 Valproic Acid affects the expression of SPARC mRNA CTD PMID:17963808 valproic acid increases expression ISO SPARC (Homo sapiens) 6480464 Valproic Acid results in increased expression of SPARC mRNA CTD PMID:23179753 and PMID:27188386 valproic acid affects expression ISO SPARC (Homo sapiens) 6480464 Valproic Acid affects the expression of SPARC mRNA CTD PMID:25979313 valproic acid decreases expression ISO SPARC (Homo sapiens) 6480464 Valproic Acid results in decreased expression of SPARC mRNA CTD PMID:23179753 and PMID:29154799 vancomycin decreases expression EXP 6480464 Vancomycin results in decreased expression of SPARC mRNA CTD PMID:18930951